Gene Therapy Potency Assay Summit

The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical insights back to your team. The content will focus on the “sweet spot” of drug development where potency is most critical - pre-clinical development through to commercialization.

This is the only industry-led event dedicated to covering all challenges associated with potency for gene therapy drug developers specifically. We will unite with 60+ analytical, bioassay, Quality Control, regulatory and CMC experts to bring together content that gives actionable insights by combining both strategic and technical content.

Join your peers to:

Learn how to prevent clinical holds with AGTC by applying phase appropriate adaptations to your product when dealing with the regulators
Improve potency assay techniques by ensuring transferability, reducing assay turnaround time, dealing with unknown MOA’s and investigating methods to figure out biological function with REGENXBIO and Ultragenyx
Observe the best practices for improving your cell-based assays with Sanofi and Biogen both presenting personalised case studies, including, platform approaches, automation tools and cell line development strategies
Achieve more accurate potency measurements by bridging the differences between assays to reduce bio variability, ensuring continuity throughout the product life cycle through panel discussions with Sanofi, Biogen, Sarepta, and Spark Therapeutics
Discover what mid to long term programme management will look like for the life cycle of your product with Sarepta presenting how to create a workable plan from day one and how to account for changes throughout the process